Research progress of entecavir treatment for chronic hepatitis B special patients
Qin Zhou, Zhenhua Zhang, Yafei Zhang, Xu Li
Abstract
Qin Zhou, Zhenhua Zhang, Yafei Zhang, Xu Li
Abstract
Entecavir (ETV) is a nucleoside analog antiviral agent launched in recent years.It seems to be efficient and safe in the prophylaxis and treatnent for HBV recurrence in patients after liver transplantation,chemotherapy or immunosuppressive therapy.ETV is also effective and safe to children who infected HBV in short-term follow-up.The treatment effect of ETV in three special patients as mentioned above is reviewed in this paper. Key words: Entecavir; Liver transplantation; Chemotherapy; Children
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Entecavir (ETV) is a nucleoside analog antiviral agent launched in recent years.It seems to be efficient and safe in the prophylaxis and treatnent for HBV recurrence in patients after liver transplantation,chemotherapy or immunosuppressive therapy.ETV is also effective and safe to children who infected HBV in short-term follow-up.The treatment effect of ETV in three special patients as mentioned above is reviewed in this paper. Key words: Entecavir; Liver transplantation; Chemotherapy; Children
Key concepts: Entecavir, Medicine, Liver transplantation, Chemotherapy, Hepatitis B, Nucleoside analogue, Chronic hepatitis, Hepatitis B virus